Observational study / 2004
Higher serum iron, transferrin saturation, and copper levels were linked to an increased risk of cancer mortality in US adults.
Researchers prospectively examined serum iron, transferrin saturation (TS), copper, and zinc levels and cancer mortality among 6,244 US adults from NHANES II. Over 83,664.4 person-years of follow-up, 307 cancer deaths occurred. In multivariable-adjusted models comparing the highest (>90th percentile) to the reference level (10th-50th percentile), adjusted relative risks (RRs) were 1.86 (95% CI: 1.07-3.22) for iron, 1.82 (95% CI: 1.10-3.02) for TS, 1.89 (95% CI: 1.07-3.32) for copper, and 0.84 (95% CI: 0.53-1.33) for zinc. Analyzed continuously, each 100 microg/dl increase in iron (RR 1.66; 95% CI: 1.03-2.68), 10% increase in TS (RR 1.17; 95% CI: 1.01-1.36), and 100 microg/dl increase in copper (RR 1.98; 95% CI: 1.12-3.50) were associated with increased cancer mortality risk, while zinc was not significantly linked (RR 0.57; 95% CI: 0.16-1.96).
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 3,000 men and 3,244 women free from cancer at baseline from NHANES II
- What was measured
- Cancer mortality
THE PAPER
Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults.
Wu T, Sempos CT, Freudenheim JL, Muti P, Smit E. Ann Epidemiol, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.